A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2
Authors
Keywords
-
Journal
JCI Insight
Volume 6, Issue 8, Pages -
Publisher
American Society for Clinical Investigation
Online
2021-03-16
DOI
10.1172/jci.insight.146316
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling
- (2021) Carleen Klumpp-Thomas et al. Nature Communications
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Coronavirus Occurrence and Transmission Over 8 Years in the HIVE Cohort of Households in Michigan
- (2020) Arnold S Monto et al. JOURNAL OF INFECTIOUS DISEASES
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
- (2020) Kelvin Kai-Wang To et al. LANCET INFECTIOUS DISEASES
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
- (2020) Dora Pinto et al. NATURE
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19—Nashville, Tennessee
- (2020) William B Stubblefield et al. CLINICAL INFECTIOUS DISEASES
- Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers
- (2020) Catherine F Houlihan et al. LANCET
- SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
- (2020) Julian Braun et al. NATURE
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
- (2020) Jose Mateus et al. SCIENCE
- Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital
- (2020) Alberto L. Garcia-Basteiro et al. Nature Communications
- Clinical Validation and Performance Evaluation of the Automated Vitros Total Anti–SARS-CoV-2 Antibodies Assay for Screening of Serostatus in COVID-19
- (2020) Emily Garnett et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2
- (2020) Marina Johnson et al. JOURNAL OF CLINICAL VIROLOGY
- Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
- (2020) Mark Ainsworth et al. LANCET INFECTIOUS DISEASES
- Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
- (2020) Ellen Shrock et al. SCIENCE
- Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19
- (2020) Petra Bacher et al. IMMUNITY
- Recent endemic coronavirus infection is associated with less-severe COVID-19
- (2020) Manish Sagar et al. JOURNAL OF CLINICAL INVESTIGATION
- Human coronavirus circulation in the United States 2014–2017
- (2018) Marie E. Killerby et al. JOURNAL OF CLINICAL VIROLOGY
- Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
- (2016) Shuo Su et al. TRENDS IN MICROBIOLOGY
- First infection by all four non-severe acute respiratory syndrome human coronaviruses takes place during childhood
- (2013) Weimin Zhou et al. BMC INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More